In situ analysis of FOXP3+ regulatory T cells and myeloid dendritic cells in human colorectal cancer tissue and tumor‑draining lymph node

Gai,Xiao-Dong; Li,Chun; Song,Yang; Lei,Yan-Ming; Yang,Bao-Xue

doi:10.3892/br.2012.35

In situ analysis of FOXP3+ regulatory T cells and myeloid dendritic cells in human colorectal cancer tissue and tumor‑draining lymph node

Authors:
- Xiao-Dong Gai
- Chun Li
- Yang Song
- Yan-Ming Lei
- Bao-Xue Yang
View Affiliations

Affiliations: Department of Pathology, School of Basic Medical Sciences, Beihua University, Jilin 132013, P.R. China, Department of Pathology, The General Hospital of CNPC in Jilin, Jilin 132022, P.R. China, Department of Pharmacology, School of Basic Medical Sciences, Peking University and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing 100191, P.R. China
Published online on: October 29, 2012 https://doi.org/10.3892/br.2012.35
Pages: 207-212

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Forkhead box protein 3 (FOXP3) regulatory T cells (Tregs) are important in the maintenance of tumor immunity tolerance. Myeloid dendritic cells (mDCs) are antigen-presenting cells (APCs) specialized to initiate and regulate immunity. Tregs and mDCs are suspected of influencing the interaction between the tumor and immune system, and thus the course of tumors. However, the implication and interaction of their concurrent infitration in colorectal cancer (CRC) remain unknown. The aim of this study was to determine FOXP3+ Tregs and CD11c+ mDCs infiltration in CRC and tumor‑draining lymph node (TDLN) and to explore the clinical and pathological implication of suppressor and effector immune cell subsets. Immunohistochemical assay was conducted to assess FOXP3+ Tregs and CD11c+ mDCs infiltration in tumor tissue and in metastasis‑free TDLN (mfTDLN) and metastatic TDLN (mTDLN). The results showed that FOXP3+ Tregs and CD11c+ mDCs infiltration was higher in tumor tissue compared to adjacent normal mucosa (P<0.001). FOXP3+ Tregs infiltration was associated with advanced tumor-node-metastasis (TNM) stage and lymph node metastasis (P<0.001 and P<0.001, for TNM stage and lymph node metastasis, respectively), whereas less CD11c+ mDCs infiltration of tumor in situ was associated with deeper tumor invasion, advanced TNM stages and lymph node metastasis (P<0.05, P<0.001 and P<0.001, for tumor invasion depth, TNM stages and lymph node metastasis, respectively). Compared to mfTDLN, mTDLN was significantly enriched in FOXP3+ Tregs (P<0.001) and reduced in CD11c+ mDCs (P<0.001). The statistical analysis demonstrated no significant correlations in Tregs and mDCs infiltration. These results suggest that more FOXP3+ Tregs and less CD11c+ mDCs infiltration have stronger prognostic significance in CRC. The presence of tumor cells in mTDLN may contribute to a tolerogenic milieu and facilitate the survival of metastatic tumor cells.

View Figures

View References

1	Hori S, Nomura T and Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057–1061. 2003. View Article : Google Scholar : PubMed/NCBI
2	Fontenot JD, Gavin MA and Rudensky AY: Foxp3 programs the development and function of CD4⁺CD25⁺ regulatory T cells. Nat Immunol. 4:330–336. 2003. View Article : Google Scholar : PubMed/NCBI
3	Khattri R, Cox T, Yasayko SA and Ramsdell F: An essential role for Scurfin in CD4⁺CD25⁺ T regulatory cells. Nat Immunol. 4:337–342. 2003. View Article : Google Scholar : PubMed/NCBI
4	Nomura T and Sakaguchi S: Naturally arising CD25⁺CD4⁺ regulatory T cells in tumor immunity. Curr Top Microbiol Immunol. 293:287–302. 2005.
5	Gilliet M and Liu Y: Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. Hum Immunol. 63:1149–1155. 2002. View Article : Google Scholar : PubMed/NCBI
6	Moseman EA, Liang X, Dawson AJ, et al: Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4⁺CD25⁺ regulatory T cells. J Immunol. 173:4433–4442. 2004. View Article : Google Scholar : PubMed/NCBI
7	Sun CM, Hall JA, Blank RB, et al: Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med. 204:1775–1785. 2007. View Article : Google Scholar : PubMed/NCBI
8	Palucka K, Ueno H, Fay J and Banchereau J: Dendritic cells and immunity against cancer. J Intern Med. 269:64–73. 2011. View Article : Google Scholar : PubMed/NCBI
9	Tarbell KV, Petit L, Zuo X, Toy P, et al: Dendritic cell-expanded, islet-specific CD4⁺CD25⁺CD62L⁺ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med. 204:191–201. 2007.PubMed/NCBI
10	Dhodapkar MV and Steinman RM: Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood. 100:174–177. 2002.PubMed/NCBI
11	Liu YJ: A unified theory of central tolerance in the thymus. Trends Immunol. 27:215–221. 2006. View Article : Google Scholar : PubMed/NCBI
12	Yamazaki S, Patel M, Harper A, et al: Effective expansion of alloantigen-specific Foxp3⁺ CD25⁺ CD4⁺ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci USA. 103:2758–2763. 2006.PubMed/NCBI
13	Banerjee DK, Dhodapkar MV, Matayeva E, et al: Expansion of FOXP3 high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood. 108:2655–2661. 2006. View Article : Google Scholar : PubMed/NCBI
14	Brunkow ME, Jeffery EW, Hjerrild KA, et al: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 27:68–73. 2001. View Article : Google Scholar : PubMed/NCBI
15	Woo EY, Chu CS, Goletz TJ, et al: Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61:4766–4772. 2001.
16	Liyanage UK, Moore TT, Joo HG, et al: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol. 169:2756–2761. 2002. View Article : Google Scholar : PubMed/NCBI
17	Curiel TJ, Coukos G, Zou L, et al: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 10:942–949. 2004. View Article : Google Scholar : PubMed/NCBI
18	Viguier M, Lemaitre F, Verola O, et al: Foxp3 expressing CD4⁺CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol. 173:1444–1453. 2004.PubMed/NCBI
19	Wang HY, Lee DA, Peng G, et al: Tumor-specific human CD4⁺ regulatory T cells and their ligands: implications for immunotherapy. Immunity. 20:107–118. 2004. View Article : Google Scholar
20	Wang HY, Peng G, Guo Z, et al: Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4⁺ regulatory T cells. J Immunol. 174:2661–2670. 2005. View Article : Google Scholar : PubMed/NCBI
21	Sato E, Olson SH, Ahn J, et al: Intraepithelial CD8⁺ tumor-infiltrating lymphocytes and a high CD8⁺/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA. 102:18538–18543. 2005.
22	Valzasina B, Piconese S, Guiducci C and Colombo MP: Tumor-induced expansion of regulatory T cells by conversion of CD4⁺CD25⁻ lymphocytes is thymus and proliferation independent. Cancer Res. 66:4488–4495. 2006. View Article : Google Scholar : PubMed/NCBI
23	Rolle CE, Sengupta S and Lesniak MS: Mechanisms of immune evasion by gliomas. Adv Exp Med Biol. 746:53–76. 2012. View Article : Google Scholar : PubMed/NCBI
24	Vinay DS, Kim CH, Choi BK and Kwon BS: Origins and functional basis of regulatory CD11c⁺ CD8⁺ T cells. Eur J Immunol. 39:1552–1563. 2009. View Article : Google Scholar : PubMed/NCBI
25	Tsujitani S, Kakeji Y, Watanabe A, et al: Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer. 66:2012–2016. 1990. View Article : Google Scholar : PubMed/NCBI
26	Schuler PJ, Börger V, Bölke E, et al: Dendritic cell generation and CD4⁺ CD25 high FOXP3⁺ regulatory T cells in human head and neck carcinoma during radio-chemotherapy. Eur J Med Res. 16:57–62. 2011.PubMed/NCBI
27	Cochran AJ, Huang RR, Lee J, et al: Tumor-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol. 6:659–670. 2006. View Article : Google Scholar : PubMed/NCBI
28	Munn DH and Mellor AL: The tumor-draining lymph node as an immune-privileged site. Immunol Rev. 213:146–158. 2006. View Article : Google Scholar : PubMed/NCBI
29	Shurin MR, Shurin GV, Lokshin A, et al: Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis Rev. 25:333–356. 2006. View Article : Google Scholar : PubMed/NCBI
30	Zou W, Machelon V, Coulomb-L’Hermin A, et al: Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med. 7:1339–1346. 2001. View Article : Google Scholar : PubMed/NCBI
31	Sharma MD, Baban B, Chandler P, et al: Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest. 117:2570–2582. 2007. View Article : Google Scholar
32	Hubert P, Jacobs N, Caberg JH, et al: The cross-talk between dendritic and regulatory T cells: good or evil? J Leukoc Biol. 82:781–794. 2007. View Article : Google Scholar : PubMed/NCBI
33	Battaglia A, Buzzonetti A, Baranello C, et al: Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer. Cancer Immunol Immunother. 58:1363–1373. 2009. View Article : Google Scholar : PubMed/NCBI